Log in to save to my catalogue

Topical paromomycin for New World cutaneous leishmaniasis

Topical paromomycin for New World cutaneous leishmaniasis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2252319599

Topical paromomycin for New World cutaneous leishmaniasis

About this item

Full title

Topical paromomycin for New World cutaneous leishmaniasis

Publisher

United States: Public Library of Science

Journal title

PLoS neglected tropical diseases, 2019-05, Vol.13 (5), p.e0007253

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Paromomycin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL) lesions caused by Leishmania major in Tunisia. Cure rates of an index lesion were approximately 80%. As a follow on, we conducted a similar Phase 3 trial in Panama to demonstrate the efficacy of these treatments against New World species. The prim...

Alternative Titles

Full title

Topical paromomycin for New World cutaneous leishmaniasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2252319599

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2252319599

Other Identifiers

ISSN

1935-2735,1935-2727

E-ISSN

1935-2735

DOI

10.1371/journal.pntd.0007253

How to access this item